| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 4 May 2009 Last Split | - IPO Date |
Woori Bio Co., Ltd. is distinguished in the biotechnology landscape, focusing on the development, manufacturing, and distribution of innovative healthcare products and services. The company’s mission is to enhance human health and well-being through its commitment to research and innovation in various biotechnological fields, encompassing pharmaceuticals, biochemistry, and regenerative medicine. Woori Bio stands at the forefront of medical technology progression, significantly impacting the pharmaceutical, healthcare, and possibly agricultural sectors by pioneering in the creation of biosimilar drugs and advanced medical solutions. This commitment places Woori Bio at the heart of the ever-evolving biotechnology industry, where its contributions to medical science are vital in inventing new treatments and therapies aimed at improving life quality across the globe.
The offerings of Woori Bio Co., Ltd. cover a broad spectrum in the biotechnology sector, including: